Adell Harriman & Carpenter Inc Pfizer Inc Transaction History

Adell Harriman & Carpenter Inc

$1.38 Trillion
Q3 2024

A detailed history of Adell Harriman & Carpenter Inc transactions in Pfizer Inc stock. As of the latest transaction made, Adell Harriman & Carpenter Inc holds 18,396 shares of PFE stock, worth $488,597. This represents 0.04% of its overall portfolio holdings.

Number of Shares

18,396

Previous 16,986 8.3%

Holding current value

$488,597

Previous $475 Million 12.02%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$27.7 - $31.39 $39,057 - $44,259	1,410 Added 8.3%	18,396 $532 Million
Q2 2024 Aug 01, 2024	SELL	$25.26 - $29.6 $393,727 - $461,375	-15,587 Reduced 47.85%	16,986 $475 Million
Q1 2024 Apr 25, 2024	SELL	$25.89 - $29.73 $1.2 Million - $1.37 Million	-46,249 Reduced 58.68%	32,573 $904 Million
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $1.46 Million - $1.89 Million	-55,825 Reduced 41.46%	78,822 $2.27 Billion
Q3 2023 Nov 07, 2023	SELL	$32.09 - $37.51 $575,020 - $672,141	-17,919 Reduced 11.75%	134,647 $4.47 Billion
Q2 2023 Aug 04, 2023	BUY	$36.12 - $41.79 $255,621 - $295,747	7,077 Added 4.86%	152,566 $5.59 Billion
Q1 2023 May 03, 2023	SELL	$39.39 - $51.28 $151,257 - $196,915	-3,840 Reduced 2.57%	145,489 $5.94 Billion
Q4 2022 Feb 03, 2023	SELL	$41.75 - $54.5 $133,099 - $173,746	-3,188 Reduced 2.09%	149,329 $7.65 Billion
Q3 2022 Nov 03, 2022	SELL	$43.76 - $53.42 $189,262 - $231,041	-4,325 Reduced 2.76%	152,517 $6.67 Billion
Q2 2022 Aug 03, 2022	BUY	$46.53 - $55.17 $269,874 - $319,986	5,800 Added 3.84%	156,842 $8.22 Million
Q1 2022 Apr 29, 2022	SELL	$45.75 - $56.69 $104,676 - $129,706	-2,288 Reduced 1.49%	151,042 $7.82 Million
Q4 2021 Feb 16, 2022	SELL	$41.32 - $61.25 $78,714 - $116,681	-1,905 Reduced 1.23%	153,330 $9.05 Million
Q3 2021 Nov 05, 2021	BUY	$39.25 - $50.42 $239,307 - $307,410	6,097 Added 4.09%	155,235 $6.68 Million
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $783,484 - $887,556	21,818 Added 17.14%	149,138 $5.84 Million
Q1 2021 May 03, 2021	BUY	$33.49 - $37.77 $84,729 - $95,558	2,530 Added 2.03%	127,320 $4.61 Million
Q4 2020 Feb 05, 2021	BUY	$33.47 - $42.56 $569,123 - $723,690	17,004 Added 15.78%	124,790 $4.59 Million
Q3 2020 Nov 06, 2020	BUY	$31.75 - $37.25 $49,530 - $58,110	1,560 Added 1.47%	107,786 $3.75 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $83,583 - $101,398	-2,775 Reduced 2.55%	106,226 $3.3 Million
Q1 2020 May 07, 2020	SELL	$27.03 - $38.62 $679,588 - $970,984	-25,142 Reduced 18.74%	109,001 $3.38 Million
Q4 2019 Feb 07, 2020	SELL	$32.92 - $37.36 $57,412 - $65,155	-1,744 Reduced 1.28%	134,143 $4.99 Million
Q3 2019 Nov 08, 2019	SELL	$32.49 - $42.13 $1.18 Million - $1.53 Million	-36,322 Reduced 21.09%	135,887 $4.63 Million
Q2 2019 Aug 07, 2019	SELL	$36.98 - $41.52 $20,708 - $23,251	-560 Reduced 0.32%	172,209 $0
Q1 2019 May 07, 2019	BUY	$37.5 - $41.2 $15,375 - $16,892	410 Added 0.24%	172,769 $0
Q4 2018 Feb 08, 2019	SELL	$38.47 - $43.86 $26,544 - $30,263	-690 Reduced 0.4%	172,359 $7.14 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $95,964 - $116,399	2,784 Added 1.64%	173,049 $0
Q2 2018 Aug 06, 2018	SELL	$32.98 - $35.16 $144,650 - $154,211	-4,386 Reduced 2.51%	170,265 $0
Q1 2018 May 08, 2018	BUY	$31.91 - $37.02 $1.05 Million - $1.22 Million	32,921 Added 23.23%	174,651 $0
Q4 2017 Feb 05, 2018	SELL	$33.26 - $35.29 $45,433 - $48,206	-1,366 Reduced 0.95%	141,730 $0
Q3 2017 Nov 06, 2017	BUY	$31.0 - $34.15 $4.44 Million - $4.89 Million	143,096	143,096 $0

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adell Harriman & Carpenter Inc, based on Form 13F filings with the SEC.

News

Stay updated on Adell Harriman & Carpenter Inc with notifications on news.

Account

Adell Harriman & Carpenter Inc Pfizer Inc Transaction History